Integrated BioPharma (OTCMKTS:INBP) Announces Earnings Results

Integrated BioPharma (OTCMKTS:INBP) issued its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share for the quarter, Zacks reports. Integrated BioPharma had a return on equity of 3.32% and a net margin of 1.26%.

Integrated BioPharma Trading Down 6.2%

Shares of Integrated BioPharma stock traded down $0.02 during trading on Wednesday, reaching $0.30. 2,700 shares of the company were exchanged, compared to its average volume of 13,904. Integrated BioPharma has a twelve month low of $0.25 and a twelve month high of $0.42. The firm has a market capitalization of $9.29 million, a price-to-earnings ratio of 30.03 and a beta of 0.53. The company has a quick ratio of 1.92, a current ratio of 4.12 and a debt-to-equity ratio of 0.01. The business has a 50-day moving average price of $0.33 and a 200-day moving average price of $0.31.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.